<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2025 (12) TMI 747 - DELHI HIGH COURT</title>
    <link>https://www.taxtmi.com/caselaws?id=783207</link>
    <description>HC upheld the assessee&#039;s claim that the license fee paid for use of goodwill and the firm&#039;s name constituted allowable business expenditure u/s 37. It held that linking consideration to a percentage of the firm&#039;s revenue was merely a computational measure and did not amount to prohibited revenue sharing under the Bar Council Rules or the Advocates Act, 1961. The payment was characterized as consideration for exploiting goodwill, not for sharing professional fees. The HC distinguished the SC ruling in Apex Laboratories, noting that, unlike explicit statutory prohibitions applicable to medical practitioners, no comparable prohibition was violated here. The appeals were dismissed and decided in favour of the assessee.</description>
    <language>en-us</language>
    <pubDate>Fri, 05 Dec 2025 00:00:00 +0530</pubDate>
    <lastBuildDate>Wed, 10 Dec 2025 12:41:57 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=870713" rel="self" type="application/rss+xml"/>
    <item>
      <title>2025 (12) TMI 747 - DELHI HIGH COURT</title>
      <link>https://www.taxtmi.com/caselaws?id=783207</link>
      <description>HC upheld the assessee&#039;s claim that the license fee paid for use of goodwill and the firm&#039;s name constituted allowable business expenditure u/s 37. It held that linking consideration to a percentage of the firm&#039;s revenue was merely a computational measure and did not amount to prohibited revenue sharing under the Bar Council Rules or the Advocates Act, 1961. The payment was characterized as consideration for exploiting goodwill, not for sharing professional fees. The HC distinguished the SC ruling in Apex Laboratories, noting that, unlike explicit statutory prohibitions applicable to medical practitioners, no comparable prohibition was violated here. The appeals were dismissed and decided in favour of the assessee.</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Fri, 05 Dec 2025 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=783207</guid>
    </item>
  </channel>
</rss>